Related Experiment Video
Updated: Aug 10, 2026

Delayed Intramyocardial Delivery of Stem Cells after Ischemia Reperfusion Injury in a Murine Model
Published on: September 3, 2020
[Stem cell therapy in ischemic heart disease]
Axel Cosmus Pyndt Diederichsen1, Jacob Eifer Møller, Malthe A M Kristiansen
1Odense Universitetshospital, Center for Stamcellebehandling, Kardiologisk Afdeling B, Odense C. a.diederichsen@dadlnet.dk
Insights
Stem cell therapy shows promise for heart repair, improving cardiac function in ischemic heart disease patients. Further research is needed to confirm safety and effectiveness for widespread clinical use.
Area of Science:
- Regenerative Medicine
- Cardiology
- Stem Cell Biology
Context:
- The heart possesses inherent regenerative capabilities.
- Stem cell therapy is an emerging treatment modality in cardiovascular medicine.
- Ischemic heart diseases remain a leading cause of mortality worldwide.
Purpose:
- To evaluate the efficacy and safety of stem cell transplantation in patients with chronic or acute ischemic heart diseases.
- To explore the potential of stem cells for myocardial regeneration and functional improvement.
Summary:
- Clinical studies involving intracoronary or intracardiac transplantation of bone marrow stem cells have demonstrated positive outcomes in patients with ischemic heart conditions.
- Treatment improved left ventricular function and regional myocardial perfusion.
- No significant complications were reported in the observed studies.
Impact:
- Stem cell therapy offers a potential new therapeutic strategy for managing ischemic heart disease.
- Evidence suggests improved cardiac function, but further research on long-term morbidity and mortality is crucial before clinical implementation.
Abstract:
Stem cell therapy is a treatment of great potential, including in cardiology. In the past few years, it has been shown that the heart has the potential for regeneration. Clinical studies have shown that intracoronary or intracardiac transplantation of bone marrow stem cells to patients with chronic or acute ischemic heart diseases improves the function and regional myocardial perfusion of the left ventricle. No significant complications have been described. However, since there is no evidence on morbidity or mortality, there is a great need for further research before the treatment can be implemented in the daily clinic.
Related Concept Videos
Stem Cell Therapy for Tissue Regeneration
Types of Stem Cells used in Stem Cell Therapy
The two main cell types that...
iPS Cell Differentiation
Stem Cell Culture

